Maxim Group Raises Target for Health in Tech (HIT) After 86{d450b60efc35a2e17361b5d57bc194208ff1ac62c46bd45a026f4271e6a4dcc4} Revenue Growth | NewsOut
Investors tracking digital insurance innovation — Health in Tech (Ticker: HIT) just earned a major vote of confidence. Maxim Group has updated its equity research report, reiterating a Buy rating and raising HIT’s 12-month price target from $250 to $325, following a standout second quarter.
The company reported $9.3M in revenue (up 86{d450b60efc35a2e17361b5d57bc194208ff1ac62c46bd45a026f4271e6a4dcc4} YoY) and $1.6M in adjusted EBITDA, exceeding expectations. Health in Tech’s growth is driven by its expanding insurtech platform, new strategic partnerships, and a wave of innovative digital insurance product launches — positioning it for scalable, long-term success.
📈 For investors focused on insurtech disruption, HIT is one to watch.
🏷️ Tags:
#HealthInTech #HITStock #Insurtech #MaximGroup #DigitalInsurance #Q2Earnings #StockMarketNews #InsuranceInnovation #InvestorAlert #ScalableGrowth #EBITDAGrowth #TechStocks #NewsOut #AnnaBerry #EquityResearch #DigitalHealth
